Blockchain Registration Transaction Record

Cybin Shifts to Nasdaq with 'HELP' Ticker for Mental Health Innovation

Cybin Inc. announces transfer from NYSE American to Nasdaq Global Market with new 'HELP' ticker symbol effective January 2026. The clinical-stage company develops next-generation mental health treatments.

This news matters because it signals Cybin's strategic positioning for growth in the competitive mental health treatment market. The move to Nasdaq typically provides companies with greater visibility among institutional investors and retail traders, potentially increasing liquidity and valuation. For patients suffering from mental health conditions like major depressive disorder and anxiety, Cybin's progress with novel treatments like CYB003 and CYB004 represents hope for more effective therapies beyond traditional antidepressants. The company's research into psychedelic-derived compounds could revolutionize mental healthcare by addressing treatment-resistant conditions. For investors, this transition may indicate confidence in Cybin's clinical pipeline and future prospects in the rapidly evolving neuropsychiatry sector.